{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:54:01Z","timestamp":1790456041595,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:p>\n                    Patients with autonomic failure have disabling orthostatic hypotension because of impaired sympathetic activity. Norepinephrine transporter blockade with atomoxetine raises blood pressure in autonomic failure by increasing synaptic norepinephrine concentrations in postganglionic sympathetic neurons. This effect requires tonic release of norepinephrine, which is decreased in patients with low sympathetic tone. We hypothesized that increasing residual sympathetic outflow with the \u03b1-2 antagonist yohimbine would potentiate the pressor effect of norepinephrine transporter blockade with atomoxetine and improve orthostatic tolerance in peripheral autonomic failure. Seventeen patients received a single oral dose of either placebo, yohimbine 5.4 mg or atomoxetine 18.0 mg, and the combination yohimbine and atomoxetine in a single blind, crossover study. Blood pressure was assessed while patients were seated and standing for \u226410 minutes before and 1 hour postdrug. Neither yohimbine nor atomoxetine significantly increased seated systolic blood pressure or orthostatic tolerance compared with placebo. The combination, however, significantly increased seated systolic blood pressure and orthostatic tolerance (\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001 and\n                    <jats:italic>P<\/jats:italic>\n                    =0.016, respectively) in a synergistic manner. The maximal increase in seated systolic blood pressure seen with the combination was 31\u00b133 mm Hg at 60 minutes postdrug. Only the combination showed a significant improvement in orthostatic symptoms. In conclusion, the combination of yohimbine and atomoxetine had a synergistic effect on blood pressure and orthostatic tolerance in peripheral autonomic failure, which may be explained by an increased release of norepinephrine in peripheral sympathetic neurons by \u03b1-2 antagonism combined with a reduced norepinephrine clearance by norepinephrine transporter blockade. Safety studies are required to address the clinical usefulness of this pharmacological approach.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.111.184812","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T00:47:10Z","timestamp":1328575630000},"page":"650-656","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":53,"title":["Synergistic Effect of Norepinephrine Transporter Blockade and \u03b1-2 Antagonism on Blood Pressure in Autonomic Failure"],"prefix":"10.1161","volume":"59","author":[{"given":"Luis E.","family":"Okamoto","sequence":"first","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyndya","family":"Shibao","sequence":"additional","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Gamboa","sequence":"additional","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Choi","sequence":"additional","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Diedrich","sequence":"additional","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish R.","family":"Raj","sequence":"additional","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie K.","family":"Black","sequence":"additional","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Robertson","sequence":"additional","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Biaggioni","sequence":"additional","affiliation":[{"name":"From the Vanderbilt Autonomic Dysfunction Center (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Division of Clinical Pharmacology (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), and Departments of Medicine (L.E.O., C.S., A.G., A.D., S.R.R., B.K.B., D.R., I.B.), Pharmacology (S.R.R., D.R., I.B.), Neurology (D.R.), Biomedical Engineering (A.D.), and Biostatistics (L.C.), Vanderbilt University School of Medicine, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","article-title":"Pharmacotherapy of autonomic failure.","author":"Shibao C","unstructured":"Shibao C, Okamoto L, Biaggioni I . Pharmacotherapy of autonomic failure. Pharmacol Ther. Epub ahead of print June 8, 2011.","journal-title":"Pharmacol Ther."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1966.tb05461.x"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540370036033"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.5.1178"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112611"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00193-4"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.089961"},{"key":"e_1_3_4_9_2","first-page":"R142","article-title":"Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers","volume":"260","author":"Grossman E","year":"1991","unstructured":"Grossman E, Rea RF, Hoffman A, Goldstein DS . Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol. 1991;260:R142\u2013R147.","journal-title":"Am J Physiol."},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198704000-00005"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02291236"},{"key":"e_1_3_4_12_2","first-page":"86","volume-title":"Manual for House Officers.","author":"Robertson D","year":"1981","unstructured":"Robertson D . Assessment of autonomic function. In: , Baughman KL, Green BM eds. Manual for House Officers. Baltimore, MD: Williams and Wilkins; 1981:86\u2013131."},{"key":"e_1_3_4_13_2","first-page":"25","volume-title":"Disorders of the Autonomic Nervous System.","author":"Mosqueda-Garcia R","year":"1995","unstructured":"Mosqueda-Garcia R . Evaluation of autonomic failure. In: , Robertson D, Biaggioni I eds. Disorders of the Autonomic Nervous System. London, United Kingdom: Harwood Academic Press; 1995:25\u201359."},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113298"},{"key":"e_1_3_4_15_2","article-title":"The orthostatic hypotension questionnaire (OHQ): validation of a novel symptom assessment scale.","author":"Kaufmann H","unstructured":"Kaufmann H, Malamut R, Norcliffe-Kaufmann L, Rosa K, Freeman R . The orthostatic hypotension questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res. Epub ahead of print November 2, 2011.","journal-title":"Clin Auton Res"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000225424.13138.5d"},{"key":"e_1_3_4_17_2","first-page":"R817","article-title":"Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans","volume":"260","author":"Esler MD","year":"1991","unstructured":"Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G . Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol. 1991;260:R817\u2013R823.","journal-title":"Am J Physiol."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000036370.31856.73"},{"key":"e_1_3_4_19_2","first-page":"R824","article-title":"Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits","volume":"260","author":"Eisenhofer G","year":"1991","unstructured":"Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK . Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Am J Physiol. 1991;260:R824\u2013R832.","journal-title":"Am J Physiol."},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072786.99163.FE"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/11536380-000000000-00000"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(02)00126-0"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.WNF.0000220822.80640.0D"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22226"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.23.2710"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.2.215"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606053142307"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.154898"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1994.tb04981.x"},{"key":"e_1_3_4_30_2","first-page":"R876","article-title":"Effects of desipramine hydrochloride on peripheral sympathetic nerve activity","volume":"258","author":"Cohen MD","year":"1990","unstructured":"Cohen MD, Finberg J, Dibner-Dunlap M, Yuih SN, Thames MD . Effects of desipramine hydrochloride on peripheral sympathetic nerve activity. Am J Physiol. 1990;258:R876\u2013R882.","journal-title":"Am J Physiol."},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.24"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.1.104"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.3.319"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.04.010"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.058727"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.111.184812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:45:11Z","timestamp":1715579111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.111.184812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.111.184812"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.111.184812","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"2011-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-01-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-02-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}